Scholars Central

Conference abstractPublished 1 Oct 2012

Translational development of enhanced potency cellular therapies

Authors: Madhusudan V. Peshwa

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

T he ability to specifically enhance biological function and control cell fate decisions without genetic modification represents a desired approach for generation of 'enhanced' potency cell therapies; as well as for 'pharmaceutical grade' primary cell / iPS cells derived tools for drug screening or therapeutics development applications. We have developed a rapid, automated, cGMP and regulatory compliant, scalable platform to process 200 billion cells in under 30 minutes by loading them with small molecule, protein, siRNA, miRNA, mRNA or plasmid DNA; singly or in combinations that permit targeted modulation of intracellular pathways resulting in augmentation of desired cellular function per defined kinetics that maps to therapeutic window for augmented efficacy. The platform allows cGMP compliant closed system cell processing and is supported by an ISO9001:2008 certified Quality System, US FDA Master File and CE Mark. Our experiences in enabling development of non-virally engineered, ?enhanced? potency, cellular therapies encompass an autologous cancer vaccine [marketed in Japan] and multiple 'engineered' immune- and stem-cell therapies is various stages of clinical and pre-clinical development. In each of these instances, the primary objective of the design and delivery of the therapeutic product is to specifically ?enhance? the desired biological activity of cells resulting in improved product efficacy profile, while permitting rapid, robust, seamless, cGMP and regulatory compliant scale-up for cost-effective clinical / commercial delivery. This presentation will summarize data on how modulation of biological activity leads to development and delivery of ?enhanced? potency immune & stem cell therapies

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Cell Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Madhusudan V. Peshwa”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels